Ligand Pharmaceuticals Incorporated - Common Stock — Quarterly Financial Statistics (NASDAQ:LGND) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends Documents

Quarterly Annual

Cash from operating activities -25.45 M15.8 M13.09 M45.91 M48.69 M24.02 M 131.71 M Cash from investing activities 4.89 M-10.67 M-353.44 M-18.1 M-94.35 M321.12 M -144.78 M Cash from financing activities -4.75 M14.99 M409.64 M8.33 M-14.13 M546.43 M 950.28 M Free cash flow -25.45 M15.8 M13.07 M45.91 M48.46 M23.99 M 131.44 M

News

Bank Of New York Mellon Hits Record High, Among Group Of 16 New To Best Stock Lists

Oil Industry Giant Valero Pops To Record High, Leads Group Of 14 Onto Best Stock Lists

Phillips 66 Hits Record High, Leads Lucky 13 Stocks Onto Best Stock Lists

Breakout Watch: Savvy Investors Bet Millions On Royalty-Fueled Pharma Stock

Palantir Popped 39% This Week, Leads 27 To Best Stock Lists

Dow Jones Futures: Cloudflare Leads 5 Software Earnings Winners Late; Jobs Report On Tap

Why This Biotech Dealmaker — Tied To Merck, Travere — Charged Higher

Dow Jones Futures: Nvidia Lifts Dow, But Google, SpaceX Skid; Sandisk, Western Digital Lead Earnings Losers Late

This Stock Of The Day Rides Big Pharma Royalties; It's Up 56% In 2026

Why Is Agenus Stock Gaining Monday? - Agenus (NASDAQ:AGEN)

Macro Note: The Tech Unwind Grew A Second Leg, And It’s Healthcare

Ligand (LGND): Expect Bright And Exciting Future For This Growing Royalty Aggregator